Researcher.Life Logo

Annals of Pharmacotherapy : Impact Factor & More

eISSN: 1542-6270pISSN: 1060-0280

Aims and Scope of Annals of Pharmacotherapy

The Annals of Pharmacotherapy is a peer-reviewed medical journal covering all aspects of pharmacotherapy. The journal was established in 1967 as Drug Intelligence. The name changed a few times during its history, to Drug Intelligence and Clinical Pharmacy (DICP) in 1969 and DICP-The Annals of Pharmacotherapy in 1989, before obtaining its current name in 1992. Less

Key Metrics

CiteScore
5
H-Index
120
Impact Factor
< 5
SJR
Q1Pharmacology (medical)
SNIP
1.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Annals of Pharmacotherapy

Annals of Pharmacotherapy Journal Specifications

Overview
Publisher SAGE PUBLICATIONS INC
Language Multi-Language
Frequency Monthly
General Details
LanguageMulti-Language
FrequencyMonthly
Publication Start Year1967
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Annals of Pharmacotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Annals of Pharmacotherapy

Relationship Between Patient's Body Mass Index and Dalbavancin's Effectiveness in the Treatment of Invasive Gram-Positive Infections.
  • 1 Jul 2026
  • The Annals of pharmacotherapy
Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.
  • 30 Jun 2026
  • The Annals of pharmacotherapy
Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.
  • 29 Jun 2026
  • The Annals of pharmacotherapy
Four-Year Evaluation of a Pharmacists-Providers Collaborative Iron Deficiency Clinic in Heart Failure Care.
  • 28 Jun 2026
  • The Annals of pharmacotherapy
Association Between Renin-Angiotensin System Inhibitors and Antiseizure Medication Burden in Critically Ill Patients With Status Epilepticus.
  • 10 Jun 2026
  • The Annals of pharmacotherapy
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
  • 6 Jun 2026
  • The Annals of pharmacotherapy
Relationship Between Patient's Body Mass Index and Dalbavancin's Effectiveness in the Treatment of Invasive Gram-Positive Infections.
  • 1 Jul 2026
  • The Annals of pharmacotherapy
Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.
  • 30 Jun 2026
  • The Annals of pharmacotherapy
Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.
  • 29 Jun 2026
  • The Annals of pharmacotherapy
Four-Year Evaluation of a Pharmacists-Providers Collaborative Iron Deficiency Clinic in Heart Failure Care.
  • 28 Jun 2026
  • The Annals of pharmacotherapy
Association Between Renin-Angiotensin System Inhibitors and Antiseizure Medication Burden in Critically Ill Patients With Status Epilepticus.
  • 10 Jun 2026
  • The Annals of pharmacotherapy
ApoC[III] You Later: A Review of Plozasiran for the Management of Familial Chylomicronemia Syndrome.
  • 6 Jun 2026
  • The Annals of pharmacotherapy

FAQs on Annals of Pharmacotherapy